Is it worth removing albumin-bound substances in hepatic encephalopathy?
Blei
A T
AT
Northwestern University Medical School, Chicago Illinois 60611, USA. andyblei@merle.acns.nwu.edu
D001569:Benzodiazepines / Q000302:isolation & purification / Q000378:metabolism*; D001781:Blood Component Removal / Q000379:methods; D016207:Cytokines / Q000302:isolation & purification / Q000378:metabolism*; D003956:Dialysis / Q000379:methods; D005112:Extracorporeal Circulation / Q000379:methods*; D006501:Hepatic Encephalopathy / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D008345:Manganese / Q000302:isolation & purification / Q000378:metabolism*; D011485:Protein Binding; D012709:Serum Albumin / Q000302:isolation & purification / Q000378:metabolism*; D014364:Tryptophan / Q000302:isolation & purification / Q000378:metabolism*
D016207:Cytokines; D012709:Serum Albumin; D001569:Benzodiazepines; D008345:Manganese; D014364:Tryptophan